Literature DB >> 18000185

Fatty liver is independently associated with alterations in circulating HDL2 and HDL3 subfractions.

Konstantinos Kantartzis1, Kilian Rittig, Alexander Cegan, Jürgen Machann, Fritz Schick, Bernd Balletshofer, Andreas Fritsche, Erwin Schleicher, Hans-Ulrich Häring, Norbert Stefan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18000185     DOI： 10.2337/dc07-1558

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  27 in total

1.  Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease.

Authors:  Naim Alkhouri; Christine Carter-Kent; Michael Elias; Ariel E Feldstein
Journal:  Clin Lipidol       Date:  2011-06-01

Review 2.  Liver fat content determined by magnetic resonance imaging and spectroscopy.

Authors:  Fabian Springer; Jürgen Machann; Claus D Claussen; Fritz Schick; Nina F Schwenzer
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

3.  Genetic variation in the GCKR gene is associated with non-alcoholic fatty liver disease in Chinese people.

Authors:  Zhen Yang; Jie Wen; Xiaoming Tao; Bin Lu; Yanping Du; Mei Wang; Xuanchun Wang; Weiwei Zhang; Wei Gong; Charlotte Ling; Songhua Wu; Renming Hu
Journal:  Mol Biol Rep       Date:  2010-07-13       Impact factor: 2.316

4.  Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Andrew Paul DeFilippis; Michael J Blaha; Seth S Martin; Robert M Reed; Steven R Jones; Khurram Nasir; Roger S Blumenthal; Matthew J Budoff
Journal:  Atherosclerosis       Date:  2013-01-29       Impact factor: 5.162

5.  The hepatokine Tsukushi is released in response to NAFLD and impacts cholesterol homeostasis.

Authors:  Mathilde Mouchiroud; Étienne Camiré; Manal Aldow; Alexandre Caron; Éric Jubinville; Laurie Turcotte; Inès Kaci; Marie-Josée Beaulieu; Christian Roy; Sébastien M Labbé; Thibault V Varin; Yves Gélinas; Jennifer Lamothe; Jocelyn Trottier; Patricia L Mitchell; Frédéric Guénard; William T Festuccia; Philippe Joubert; Christopher F Rose; Constantine J Karvellas; Olivier Barbier; Mathieu C Morissette; André Marette; Mathieu Laplante
Journal:  JCI Insight       Date:  2019-08-08

6.  Sex and race differences in the prevalence of fatty liver disease as measured by computed tomography liver attenuation in European American and African American participants of the NHLBI family heart study.

Authors:  Kari E North; Mariaelisa Graff; Nora Franceschini; Alexander P Reiner; Mary F Feitosa; John Jeffrey Carr; Penny Gordon-Larsen; Mary K Wojczynski; Ingrid B Borecki
Journal:  Eur J Gastroenterol Hepatol       Date:  2012-01       Impact factor: 2.566

Review 7.  Dyslipidemia in patients with nonalcoholic fatty liver disease.

Authors:  Hemant Chatrath; Raj Vuppalanchi; Naga Chalasani
Journal:  Semin Liver Dis       Date:  2012-03-13       Impact factor: 6.115

8.  Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile.

Authors:  Mohammad S Siddiqui; Michael Fuchs; Michael O Idowu; Velimir A Luketic; Sherry Boyett; Carol Sargeant; Richard T Stravitz; Puneet Puri; Scott Matherly; Richard K Sterling; Melissa Contos; Arun J Sanyal
Journal:  Clin Gastroenterol Hepatol       Date:  2014-10-13       Impact factor: 11.382

9.  Nonalcoholic fatty liver disease and the heart in children and adolescents.

Authors:  Lucia Pacifico; Claudio Chiesa; Caterina Anania; Antonio De Merulis; John Frederick Osborn; Sara Romaggioli; Eugenio Gaudio
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

10.  Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene.

Authors:  Konstantinos Kantartzis; Andreas Peter; Fausto Machicao; Jürgen Machann; Silvia Wagner; Ingmar Königsrainer; Alfred Königsrainer; Fritz Schick; Andreas Fritsche; Hans-Ulrich Häring; Norbert Stefan
Journal:  Diabetes       Date:  2009-08-03       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.